2Petterson F. Annual repot of theresults of the treatment in Gyneco logical cancer.Int[J].Gynecol Obester,1991,36(Supple):132-137.
3Greven KM,Lanciano RM,Corn B,et al. Pathologic Stage Ⅲ Endometrial Carcinoma:prognostic factors and patterms of recurrence[J].Cancer,1993,71(11):3697-3702.
4Kaku T, Yoshikawa H, Tsuda H, et al. Endometrial carcinoma associated with hyperplasia[J]. Gynecol Oncol, 1996,60:22-25.
5Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri:FIGO 6th annual report on the results of treatment in gynecological cancer [ J ] . Int J Gynaecol Obstet, 2006, 95(Suppl 1):S105-143.
6Yasunaga M, Yamasaki F, Tokunaga O, et al. Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis [ J ] . Int J Gyneeol Pathol, 2003, 22(4):341-346.
7Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12 333 Patients [ J ] . Cancer, 2006, 107(8):1823-1830.
8Kong A, Johnson N, Comes P, et al. Adjuvant radiotherapy for stage Ⅰ endometrial cancer [ J ] . Cochrane Database Syst Rev,2007,18 (2):CD003916.
9Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma [ J ] . Lancet,2000, 355(9213):1404-1411.
10Ludwig H. Prognostic factors in endometrial cancer [ J ] . Int J Gynaecol Obstet, 1995, 49 (Suppl):S1-7.
